SEC Info℠

Home

Search

My Interests

Help

Sign In

Please Sign In

Novartis Bioventures Ltd, et al. – ‘SC 13D’ on 10/1/14 re: Tokai Pharmaceuticals Inc – EX-99.3

On:  Wednesday, 10/1/14, at 4:15pm ET   ·   Accession #:  1193125-14-360795   ·   File #:  5-88334

Previous ‘SC 13D’:  ‘SC 13D/A’ on 2/4/11   ·   Next:  ‘SC 13D’ on 3/27/17   ·   Latest:  ‘SC 13D/A’ on 5/15/20

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

 Text Wildcards:  ? (any letter/digit),  * (many).  Search Logic:  for Documents:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).  Details... 

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/01/14  Novartis Bioventures Ltd          SC 13D                 4:275K Tokai Pharmaceuticals Inc         RR Donnelley/FA
          Novartis AG

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership           HTML     66K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     10K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML      4K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML      7K 

Exhibit 99.3

Power of Attorney

We, the undersigned, under the authority granted to each of us to sign jointly on behalf of Novartis AG, hereby grant powers to Simon Zivi, Rebecca White, Michael Jones, David Middleton, Bartosz Dzikowski, Campbell Murray, and Reinhard Ambros and constitute and appoint any two of them jointly as our true and lawful attorneys and representatives and to act on our behalf and to sign filings to be made with the U.S. Securities and Exchange Commission (the “SEC”) relating to the shares of Tokai Pharmaceuticals, Inc. held by Novartis BioVentures, Ltd, an indirect subsidiary of Novartis AG, as required by the SEC (the “SEC Filings”), and to undertake and carry out all tasks and formalities on our behalf which may be required in connection with giving effect to the SEC Filings.

We, the undersigned, undertake to ratify and confirm whatever our true and lawful attorneys do or purport to do in good faith in the exercise of any power conferred by this Power of Attorney.

We, the undersigned, declare that a person who deals with our true and lawful attorneys in good faith may accept a written statement signed by such attorneys to the effect that this Power of Attorney has not been revoked as conclusive evidence of that fact.

The authority granted by this Power of Attorney shall expire immediately after the SEC Filings are no longer required.

IN WITNESS WHEREOF, this Power of Attorney is duly signed on this 29^th day of August 2014.